urse-led, screening-triggered early specialized palliative care intervention program for advanced lung cancer patients: a randomized controlled trial
Phase 3
- Conditions
- Advanced Lung Cancer
- Registration Number
- JPRN-UMIN000025491
- Lead Sponsor
- ational Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 204
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Already consulted outpatient palliative medicine clinic or outpatient psycho-oncology clinic before entry to this study, and scheduled to receive the medical care subsequently (2) Already received intervention of specialty palliative care service before entry to this study (3) With severe cognitive impairment (4) unable to comprehend Japanese (5) Already participate in other intervention studies which prohibit participation in this study. (6) Considered ineligible for this study by the physician in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change in the score on the Functional Assessment of Cancer Therapy-Lung Trial Outcome Index (FACT-L TOI) from baseline to 3 months
- Secondary Outcome Measures
Name Time Method